Combined effect of liposomal and conventional amphotericin B in a mouse model of systemic infection with Candida albicans

Journal of Chemotherapy
M KretschmarT Nichterlein

Abstract

Amphotericin B may be employed as a potentially toxic deoxycholate complex or incorporated in liposomes and other particles which have an altered tissue distribution. A combination of both preparations could help to overcome the drawbacks of the individual preparations. We have employed a mouse model of systemic infection with Candida albicans to investigate whether this assumption was essentially true. We found that the combination of low dosages of both preparations (0.5 mg/kg of body weight/day of conventional and 0.5 mg kg of body weight/day liposomal amphotericin B) was more efficient than a similar dosage of conventional amphotericin B (1 mg/kg of body weight/day) in the liver and similar or higher dosages of liposomal amphotericin B (1 or 5 mg/kg of body weight/day) in the kidneys.

References

Mar 1, 1995·Antimicrobial Agents and Chemotherapy·A M SugarM Picard
May 1, 1996·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J W Hiemenz, T J Walsh
Jul 1, 1997·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J E EdwardsM White
Oct 14, 1998·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·A Wong-BeringerB J Guglielmo
Apr 1, 2000·Journal of Neuroimmunology·M KretschmarT Nichterlein
Apr 19, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J H RexJ E Edwards
Apr 19, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D A StevensG A Pankey
Oct 29, 2000·International Journal of Antimicrobial Agents·M Aoun
Mar 20, 2001·Current Pharmaceutical Design·S Arikan, J H Rex
Aug 30, 2001·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·J TollemarO Ringdén
Jan 22, 2002·The Journal of Antimicrobial Chemotherapy·Jill Adler-Moore, Richard T Proffitt
Jan 22, 2002·The Journal of Antimicrobial Chemotherapy·Gilbert Deray
Jan 22, 2002·The Journal of Antimicrobial Chemotherapy·Cosimo Lequaglie

❮ Previous
Next ❯

Citations

Mar 11, 2015·Antimicrobial Agents and Chemotherapy·Seyedmojtaba SeyedmousaviJohan W Mouton
May 3, 2008·Journal of Pharmaceutical Sciences·Giulia BonacucinaGiovanni F Palmieri

❮ Previous
Next ❯

Related Concepts

Related Feeds

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.